Sens. Orrin Hatch, R-Utah, Richard Burr, R-N.C., Lamar Alexander, R-Tenn., and Johnny Isakson, R-Ga., are concerned with the FDA's use of draft guidelines governing drugs and medical devices. The draft guidelines, which are issued for comment purposes only, are "increasingly becoming default FDA policy" and "are not being revised, finalized, or withdrawn in a timely manner," the senators wrote in a letter to FDA Commissioner Dr. Margaret Hamburg.
GOP senators take issue with FDA's use of draft guidances
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan